UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 billion, continues to navigate a complex landscape of opportunities and challenges as it maintains its position as a dominant force in the healthcare industry.

UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider services overcame rising costs and a cyberattack.

UnitedHealth Group beat estimates for fourth quarter profit as the Eden Prairie-based health care giant released its first earnings report since the fatal ambush last month of top executive Brian Thompson in New York City.

In his first public remarks since the murder of UnitedHealthcare CEO Brian Thompson last month and the backlash against the insurance industry it provoked, Witty said the healthcare conglomerate is looking for ways to simplify and accelerate its prior authorization processes. He did not offer specifics.

UnitedHealth Group reported bottom-line earnings that surpassed estimates despite regulatory challenges impacting revenue.

UNH stock is finally returning to form after UnitedHealthcare CEO Brian Johnson was gunned down outside an investor meeting in Midtown Manhattan on December 4, leading to a weeklong manhunt that brought light to UnitedHealth’s record of denying health claims and general unpopularity with the public.

UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/98.YCWzV16B.js

(Reuters) - Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly results on Thursday, after its investor day presentations were canceled last month by the murder of executive Brian Thompson outside the New York hotel where the meeting was set to take place.

UnitedHealth Group reported fourth-quarter revenue below Wall Street estimates on Thursday, hurt by weakness in its health insurance unit, sending the healthcare conglomerate's shares down about 3% in

The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch than the past two years.